SMS Pharmaceuticals Limited Reports Unaudited Financial Results for Q1 FY27

SMS Pharmaceuticals Limited, headquartered in Hyderabad, Telangana, has officially released its standalone and consolidated unaudited financial performance metrics for the first quarter ended June 30, 2026. The results demonstrate steady operational performance alongside solid bottom-line growth on a year-over-year basis.

Standalone Performance Summary

For the quarter ended June 30, 2026, SMS Pharmaceuticals reported a standalone revenue from operations of ₹20,696.49 lakhs. While this marks a sequential reduction from ₹23,794.75 lakhs recorded in the preceding quarter ended March 31, 2026, it represents a year-over-year growth of 5.57% compared to ₹19,604.71 lakhs in the corresponding quarter of the previous year (Q1 FY26).

Adding other income of ₹174.44 lakhs, the company's total standalone income for Q1 FY27 stood at ₹20,870.93 lakhs, compared to ₹24,052.19 lakhs in Q4 FY26 and ₹19,664.02 lakhs in Q1 FY26.

Expense Breakdown (Standalone)

Total standalone expenses for the quarter amounted to ₹18,056.51 lakhs, significantly lower than the ₹21,347.63 lakhs registered in Q4 FY26. Key cost items included:

Cost of Materials Consumed: ₹13,572.13 lakhs (vs. ₹12,831.07 lakhs in Q4 FY26)

Changes in Inventories: ₹(2,384.73) lakhs

Manufacturing Expenses: ₹1,951.54 lakhs

Employee Benefits Expense: ₹2,330.42 lakhs

Finance Cost: ₹549.95 lakhs

Depreciation and Amortization Expense: ₹999.08 lakhs

Other Expenses: ₹1,038.12 lakhs

Standalone Profitability

The company recorded a profit before tax (PBT) of ₹2,814.42 lakhs for Q1 FY27, showing an upward trajectory compared to ₹2,704.56 lakhs in Q4 FY26 and ₹2,386.18 lakhs in Q1 FY26 (a 17.95% YoY increase).

After deducting total tax expenses of ₹701.16 lakhs (comprising ₹610.00 lakhs in current tax and ₹91.16 lakhs in deferred tax), standalone net profit after tax (PAT) reached ₹2,113.26 lakhs. This reflects a year-over-year profit expansion of 16.07% over ₹1,820.75 lakhs achieved in Q1 FY26. Total comprehensive income for the quarter stood at ₹2,105.78 lakhs, with basic and diluted earnings per share (EPS) at ₹2.26 (face value of ₹1/- per share).

Consolidated Performance Summary

On a consolidated level, SMS Pharmaceuticals mirrored its standalone operations, reporting revenue from operations of ₹20,696.49 lakhs and total income of ₹20,870.93 lakhs for Q1 FY27.

Expenses & Margins (Consolidated)

Consolidated total expenses came in at ₹18,150.43 lakhs for the quarter. Major expenditure lines included:

Cost of Materials Consumed: ₹13,664.68 lakhs

Changes in Inventories: ₹(2,412.93) lakhs

Manufacturing Expenses: ₹1,951.60 lakhs

Employee Benefits Expense: ₹2,354.02 lakhs

Finance Cost: ₹549.95 lakhs

Depreciation and Amortization: ₹999.08 lakhs

Other Expenses: ₹1,044.03 lakhs

Consolidated profit before tax stood at ₹2,720.50 lakhs, compared to ₹2,706.68 lakhs in Q4 FY26 and ₹2,436.90 lakhs in Q1 FY26.

Net Profit & Associate Share

After accounting for total tax expenses of ₹700.40 lakhs, net profit after tax prior to associate share reached ₹2,020.10 lakhs.

Including a ₹70.80 lakh share of profit from associate entities (net of tax), total consolidated net profit attributable to equity shareholders arrived at ₹2,090.90 lakhs, representing a 2.04% increase over ₹2,049.05 lakhs in Q1 FY26.

After factoring in other comprehensive loss of ₹6.50 lakhs (net of tax), total consolidated comprehensive income attributable to shareholders stood at ₹2,084.40 lakhs. Consolidated basic and diluted EPS for Q1 FY27 stood at ₹2.23 per share.

Equity & Capital Structure

Paid-Up Equity Share Capital: Remained stable at ₹936.52 lakhs (comprising shares of face value ₹1/- each).

Other Equity (Excluding Revaluation Reserves): Stood at ₹79,542.17 lakhs on a standalone basis and ₹77,644.36 lakhs on a consolidated basis.

Shares of SMS Pharmaceuticals Limited was last trading in BSE at Rs. 374.20 as compared to the previous close of Rs. 373.75. The total number of shares traded during the day was 5938 in over 240 trades.

The stock hit an intraday high of Rs. 381.15 and intraday low of 366.50. The net turnover during the day was Rs. 2225535.00.

Source : Equity Bulls

Keywords

SMSPharmaceuticals INE812G01025 Q1FY27 Q1FY2027 ResultUpdate